glp-1 loss of muscle mass Weight with medicines does not result in a disproportionate loss or function in obese mice and humans How Much Muscle Are GLP-1

Every so often, an idea appears that forces me to pause, re-examine the science, and ask whether we have misunderstood something important

Wilson JM, Nikooienejad A, Robins DA, Roell WC, Riesmeyer JS, Haupt A, Duffin KL, Taskinen MR, Ruotolo G

As you adapt, the side effects will decrease

Emerging evidence suggests that treatment with the dual GLP-1 and GIP receptor agonist, tirzepatide, might prove even more potent than a GLP-1RA alone, to ameliorate NAFLD

GLP-1R agonist treatment also leads to a mild decrease in cholesterol levels (total, LDL, and triglyceride), an additional factor that participates in the pathogenesis and progression of such kidney disease [76]

It is the target for several FDA-approved antidiabetic medications called incretin mimetics: These incretin mimetics are glucagon-like peptide 1 (GLP-1) analogs that mimic the physiological action of GLP-1 and thereby potentiates the incretin effect in type 2 diabetic patients